What is NDC 60687-931?

60687-931 is the product NDC for Bromocriptine Mesylate, Bromocriptine mesylate 2.5 mg/1 tablet, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.

American Health Packaging, NDC labeler code 60687. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bromocriptine Mesylate?

8 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bromocriptine Mesylate NDC 60687-931

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-931Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0931Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-931-21	6068709312160687093121	30 BLISTER PACK in 1 CARTON (60687-931-21) / 1 TABLET in 1 BLISTER PACK (60687-931-11)Marketed from Jun 12, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bromocriptine Mesylate
Generic name (nonproprietary): bromocriptine mesylate
Active ingredients: Bromocriptine mesylate — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: American Health PackagingNDC labeler code 60687
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 017962
Marketing start: Jun 12, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Ergolines (Chemical structure)
Identifiers: Product ID 60687-931_5411f81a-2433-5acf-e063-6294a90a838cSPL ID 5411f81a-2433-5acf-e063-6294a90a838cSPL set ID ddd292a5-72af-448f-8b88-cc4fd99ec783RxCUI 197411UNII FFP983J3OD
Pharmacologic class: Ergot Derivative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687093121 followed by a unit qualifier and the quantity

Package 60687-0931-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 12, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE Hyperprolactinemia-Associated Dysfunctions Bromocriptine mesylate is indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism. Bromocriptine mesylate treatment is indicated in patients with prolactin-secreting adenomas, which may be the basic underlying endocrinopathy contributing to the above clinical presentations. Reduction in tumor size has been demonstrated in both male and female patients with macroadenomas. In cases where adenectomy is elected, a course of bromocriptine mesylate therapy may be used to reduce the tumor mass prior to surgery. Acromegaly Bromocriptine …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60687-931

What is NDC 60687-931?: 60687-931 is the product NDC for Bromocriptine Mesylate, Bromocriptine mesylate 2.5 mg/1 tablet, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bromocriptine Mesylate.
What is the active ingredient?: Bromocriptine mesylate.
Who is the labeler?: American Health Packaging, NDC labeler code 60687. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bromocriptine Mesylate?: 8 other product NDCs are listed under this name. See all Bromocriptine Mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bromocriptine Mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bromocriptine mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4628	70518-4628-00
Bromocriptine Mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-951	70954-0951-1070954-0951-20
Bromocriptine Mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-978	70954-0978-1070954-0978-20
Bromocriptine mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	Padagis US LLC	0574-0106	00574-0106-0100574-0106-03
Bromocriptine Mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	Mylan Pharmaceuticals Inc.	0378-7096	00378-7096-0100378-7096-93
Bromocriptine mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	Zydus Lifesciences Limited	65841-654	65841-0654-0165841-0654-06
Bromocriptine mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	68382-110	68382-0110-0168382-0110-06
Bromocriptine mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	Sandoz Inc	0781-5325	00781-5325-0100781-5325-31

Other NDCs under NDA 017962

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 017962
Product	Strength	Form · route	Labeler	Product NDC
Bromocriptine Mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-951
Bromocriptine Mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-978